
|Videos|February 9, 2022
Urology Times 50 Innovations Series: Genetic testing for prostate cancer
Author(s)Urology Times staff
Advertisement
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Veda N. Giri, MD, discusses the role genetic testing has played in a new era of prostate cancer therapeutics. Giri is a Professor in Medical Oncology and Cancer Biology at Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
Alternative BCG strains may help address ongoing supply challenges in NMIBC
3
Doublet or triplet? Urologists weighs in on mCSPC options
4
Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA
5












































